30 results on '"Bujkiewicz, S"'
Search Results
2. Use of stochastic web patterns to control electron transport in semiconductor superlattices
3. Quantum chaotic electron transport in superlattices
4. 2D chaotic quantum states in superlattices
5. MSR110 Four Alternative Methodologies for Simulated Treatment Comparison: How Could the Use of Simulation be Re-Invigorated.
6. Chaos-induced orbit delocalization and complex Bloch oscillations in semiconductor superlattices
7. PCN416 NETWORK META-ANALYSIS FOR SURROGATE ENDPOINT EVALUATION IN ADVANCED COLORECTAL CANCER: A BAYESIAN APPROACH.
8. PMS42 Bayesian Meta-Analysis Methods for Synthesis of DATA from Randomised Controlled Trials and Single-Arm Studies.
9. PMS65 USE OF REGISTRY DATA AS A SOURCE OF REAL WORLD EVIDENCE IN BRIDGING DISCONNECTED NETWORKS OF FIRST AND SECOND LINES OF THERAPIES IN RHEUMATOID ARTHRITIS.
10. HTA87 Mapping Accumulating Evidence Across Multiple Indications in Oncology Health Technology Assessment.
11. PRM75 - Meta-Analysis For The Evaluation Of Multiple Surrogate Endpoints.
12. Graphical Interactive Meta-Analysis Module for Facilitating Evidence-Based Decision Making in Health Care.
13. Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates.
14. Bivariate Indirect Comparison Meta-Analysis Model in Economic Evaluation of Cancer Treatments.
15. PCN285 Surrogate Endpoints in Advanced Colorectal Cancer in Subgroups of Patients Defined By the KRAS Biomarker Status.
16. MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab.
17. SA13 Can Models for Surrogate Endpoint Evaluation Be Used to Predict Generic Measures From Disease Specific Measures of Health Related Quality of Life Based on Summary Data?
18. MSR21 Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship Between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer.
19. PCN49 - Using Simulated Individual Patient Data (IPD) From Published Registry and Ipd From The Seer-Medicare Registry To Extrapolate Results From Randomised Clinical Trials (RCTS) in Metastatic Melanoma.
20. HTA266 Hierarchical Network Meta-Analysis Models for the Inclusion of Randomised and Observational Comparative Studies in Evidence Synthesis.
21. P42 Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
22. Network Meta-Analysis of Biological Response Modifiers in Rheumatoid arthritis Including real World Evidence at Multiple time Points.
23. The Use Of Real World Evidence (Rwe) To Investigate The Overall Treatment Effects Of Different Lines Of Therapy In Rheumatoid Arthritis.
24. Network Meta-Analysis Of Multiple Outcomes Incorporating Dose-Related Constraints: Application To Overactive Bladder Syndrome.
25. PUK2 - Comparative Efficacy of Interventions for Overactive Bladder Syndrome: A Systematic Review And Network Meta-Analysis.
26. Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
27. Hierarchical Network Meta-Analysis Incorporating Ordering Constraints on Increasing Doses of Interventions - Application to Overactive Bladder Syndrome.
28. Children's Cancer and Leukemia Group (CCLG) Study of Hyperfractionated Accelerated Radiotherapy (HART) with Chemotherapy for M1–3 Medulloblastoma (MB)
29. PRM195 - The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis: A Case Study in Rheumatoid Arthritis.
30. PRM53 - Choice Of Distributional Assumptions In Meta-Analysis For The Evaluation Of Surrogate Endpoints.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.